Combining antiangiogenic therapy with adoptive cell immunotherapy exerts better antitumor effects in non-small cell lung cancer models.

PLoS One · 2013 · PMC3683034 · PMID 23799045

Europe PMC DOI

hedged sentence

0.3240

closest p · 6.5× alpha

0.3240

boldest claim

The sentences

did not reach statistical significancep = 0.324not close (p > 0.1)

In A549 lung carcinoma model, we found that rh-endostatin slightly limited tumor growth compared with NS control, but did not reach statistical significance (929.46±471.70 vs 1251.8±531.75, p = 0.324).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.